Tissue Diagnostic Market
Tissue Diagnostic Market - Global Industry Assessment & Forecast
#
Pages:
140
Base Year:
2022
Mar - 2022
Format:
Report Code:
VMR-1379
Segments Covered
By
Product Consumables, Instruments
-
By
Technology Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining
-
By
Disease Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Other Diseases
-
By
End User Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, Other End Users
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 3831.90 Million |
 Revenue 2030:
|
USD 6107.47 Million |
 Revenue CAGR
(2023 - 2030): |
6.00% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Tissue Diagnostic Market Segment Analysis
- Tissue Diagnostic Product Outlook (Revenue, USD Million, 2018 - 2030)
- Consumables
- Instruments
- Tissue Diagnostic Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Tissue Diagnostic Disease Outlook (Revenue, USD Million, 2018 - 2030)
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Tissue Diagnostic End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Tissue Diagnostic Market, by Product
- Consumables
- Instruments
-
North America Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
-
North America Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
-
North America Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- U.S.
- U.S. Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- U.S. Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- U.S. Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- U.S. Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- U.S. Tissue Diagnostic Market, by Product
- Canada
- Canada Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Canada Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Canada Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Canada Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Canada Tissue Diagnostic Market, by Product
-
Mexico
- Mexico Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Mexico Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Mexico Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Mexico Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Mexico Tissue Diagnostic Market, by Product
-
North America Tissue Diagnostic Market, by Product
- Europe
-
Europe Tissue Diagnostic Market, by Product
- Consumables
- Instruments
-
Europe Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
-
Europe Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
-
Europe Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- U. K.
- U.K. Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- U.K. Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- U.K. Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- U.K. Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- U.K. Tissue Diagnostic Market, by Product
- France
- France Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- France Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- France Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- France Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- France Tissue Diagnostic Market, by Product
-
Germany
- Germany Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Germany Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Germany Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Germany Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Germany Tissue Diagnostic Market, by Product
-
Italy
- Italy Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Italy Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Italy Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Italy Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Italy Tissue Diagnostic Market, by Product
-
Spain
- Spain Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Spain Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Spain Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Spain Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Spain Tissue Diagnostic Market, by Product
-
Rest of Europe
- Rest of Europe Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Rest of Europe Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Rest of Europe Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Rest of Europe Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Rest of Europe Tissue Diagnostic Market, by Product
-
Europe Tissue Diagnostic Market, by Product
- Asia Pacific
-
Asia Pacific Tissue Diagnostic Market, by Product
- Consumables
- Instruments
-
Asia Pacific Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
-
Asia Pacific Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
-
Asia Pacific Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- China
- China Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- China Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- China Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- China Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- China Tissue Diagnostic Market, by Product
- Japan
- Japan Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Japan Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Japan Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Japan Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Japan Tissue Diagnostic Market, by Product
-
Germany
- Germany Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Germany Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Germany Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Germany Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Germany Tissue Diagnostic Market, by Product
-
India
- India Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- India Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- India Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- India Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- India Tissue Diagnostic Market, by Product
-
South Korea
- South Korea Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- South Korea Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- South Korea Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- South Korea Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- South Korea Tissue Diagnostic Market, by Product
-
South East Asia
- South East Asia Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- South East Asia Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- South East Asia Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- South East Asia Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- South East Asia Tissue Diagnostic Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Rest of Asia Pacific Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Rest of Asia Pacific Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Rest of Asia Pacific Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Rest of Asia Pacific Tissue Diagnostic Market, by Product
-
Asia Pacific Tissue Diagnostic Market, by Product
- Latin America
-
Latin America Tissue Diagnostic Market, by Product
- Consumables
- Instruments
-
Latin America Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
-
Latin America Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
-
Latin America Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Brazil
- Brazil Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Brazil Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Brazil Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Brazil Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Brazil Tissue Diagnostic Market, by Product
- Argentina
- Argentina Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Argentina Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Argentina Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Argentina Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Argentina Tissue Diagnostic Market, by Product
-
Rest of Latin America
- Rest of Latin America Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Rest of Latin America Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Rest of Latin America Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Rest of Latin America Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Rest of Latin America Tissue Diagnostic Market, by Product
-
Latin America Tissue Diagnostic Market, by Product
- Middle East & Africa
-
Middle East & Africa Tissue Diagnostic Market, by Product
- Consumables
- Instruments
-
Middle East & Africa Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
-
Middle East & Africa Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
-
Middle East & Africa Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- GCC Countries
- GCC Countries Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- GCC Countries Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- GCC Countries Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- GCC Countries Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- GCC Countries Tissue Diagnostic Market, by Product
- South Africa
- South Africa Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- South Africa Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- South Africa Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- South Africa Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- South Africa Tissue Diagnostic Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Tissue Diagnostic Market, by Product
- Consumables
- Instruments
- Rest of Middle East & Africa Tissue Diagnostic Market, by Technology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology and Workflow Management
- Special Staining
- Rest of Middle East & Africa Tissue Diagnostic Market, by Disease
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Other Diseases
- Rest of Middle East & Africa Tissue Diagnostic Market, by End User
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Other End Users
- Rest of Middle East & Africa Tissue Diagnostic Market, by Product
-
Middle East & Africa Tissue Diagnostic Market, by Product
- North America
Vantage Market
Research | 16-Mar-2022
FAQ
Frequently Asked Question
What is the global demand for Tissue Diagnostic in terms of revenue?
-
The global Tissue Diagnostic valued at USD 3831.90 Million in 2022 and is expected to reach USD 6107.47 Million in 2030 growing at a CAGR of 6.00%.
Which are the prominent players in the market?
-
The prominent players in the market are Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Qiagen (Germany), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), Dipath S.P.A. (Italy)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.00% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Tissue Diagnostic include
- rising cancer prevalence, improved infrastructure for cancer diagnostics, rising healthcare spending, and various technological advancements
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Tissue Diagnostic in 2022.
